Illumina Inc. First-Quarter Results: NovaSeq Still the Gift That Keeps on Giving [The Motley Fool]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: The Motley Fool
The genomic-sequencing pioneer's momentum continues thanks to sustained strong sales for its NovaSeq system launched last year. Illumina ( NASDAQ:ILMN ) shareholders have basked in the success of the company's NovaSeq system. The company enjoyed a tremendous year in 2017 thanks largely to a better-than-expected rollout of the gene-sequencing system. Heading into the first quarter of 2018, there was every reason to anticipate that the momentum would continue. And that's exactly what happened. Illumina reported its first-quarter results after the market closed on Tuesday. The genomic-sequencing pioneer yet again delivered a solid performance. Here are the highlights. Image source: Getty Images. Illumina results: The raw numbers Metric Q1 2018 Q1 2017 Year-Over-Year Change Sales $782 million $598 million 30.8% Net income from continuing operations $208 million $367 million (43.3%) Adjuste
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Global Microfluidics Market Size To Worth USD 65.90 Billion By 2033 | CAGR Of 7.36% [Yahoo! Finance]Yahoo! Finance
- Illumina (NASDAQ:ILMN) investors are sitting on a loss of 71% if they invested three years ago [Yahoo! Finance]Yahoo! Finance
- These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar [Yahoo! Finance]Yahoo! Finance
- United States Liquid Biopsy Market Analysis Report 2024: A $3.68 Billion Industry by 2032 from $1.06 Billion in 2023 - Emphasis on Companion Diagnostics, Increasing acceptance of Non-invasive Techniques [Yahoo! Finance]Yahoo! Finance
- Global Targeted Sequencing Industry Research 2023-2033: Burgeoning Opportunities Adoption in Targeted Therapeutics in Oncology and Use in Clinical Research and Trials for Better Disease Pathogenesis [Yahoo! Finance]Yahoo! Finance
ILMN
Earnings
- 2/8/24 - Beat
ILMN
Sec Filings
- 4/24/24 - Form 3
- 4/24/24 - Form 3
- 4/12/24 - Form 8-K
- ILMN's page on the SEC website